Delivery Order SPE2DB22D2007-SPE2DB25FJ3BH
Award Date 7/16/25
Potential Completion Date 7/17/25
Potential Value $45K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of STELARA 45 MG/0.5 ML SYRINGE 0.5ML pharmaceuticals to the Defense Logistics Agency (DLA). The $15,182.36 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on July 16, 2025 with a completion date of July 17, 2025. The contract is not a set-aside and was competitively awarded. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
- This federal contract award is for the delivery of STELARA 45 MG/0.5 ML syringes to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $7,369.92 and an ultimate completion date of December 5, 2024. This order is a part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- The federal contract award is for the delivery of STELARA 45 MG/0.5 ML SYRINGE 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The $18,614.28 firm-fixed-price delivery order was awarded on May 24, 2024 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a completion date of May 28, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical for providing a...
- This federal contract award is for the delivery of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $3,656.26 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 5, 2024, with a completion date of September 6, 2024. This contract is not set aside for any specific business category. Amerisourcebergen Drug Corp has been awarded numerous Indefinite Delivery...
- This federal contract award is for the delivery of STELARA 45 MG/0.5 ML syringes to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 12, 2024 for a ceiling value of $23,733.48. The contract is a delivery order issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November...
- This federal contract award is for the delivery of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The award, valued at $7,956.68, was granted on July 3, 2024 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a completion date of July 5, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type. This award is associated with Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with...
- This federal contract award is for the delivery of STELARA 45 MG/0.5 ML SYRINGE 0.5ML medical supplies, with an ultimate completion date of November 8, 2023. The contract, valued at $14,171.46, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there was no set-aside designation used. Amerisourcebergen Drug Corp holds a larger...
- This federal contract award is for the delivery of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $30,156.28, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 15, 2024 with a completion date of November 18, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is for the delivery of STELARA 90 MG/ML syringes to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $42,506.27, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of October 28, 2024. The contract is not designated as a set-aside and appears to be part of a larger...
- This federal contract award is for the delivery of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $7,617.86. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of June 5, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the...